2024-10-28 20:26:35
FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke
Health/ 2023-07-22
FUJIFILM Diosynth Biotechnologies and Ne...

STATE COLLEGE,Pa.,Sept. 13,2021-- FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturi...

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
Corporate/ 2023-07-23
RedHill Biopharma Accelerates Ongoing U....

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release